DSE : ASIATICLAB

Asiatic Laboratories Limited — Financial statements

Pharmaceutical Preparations · Bangladesh

Last price 108 BDT (At close: Oct 29, 2026) · Market cap 13.22B

Latest research: Asiatic Laboratories financial analysis: 9M FY26 sales +99%, IPO funds unused, lock-in extended (Oct 2026) · Asiatic Laboratories: sales doubled in 9M FY2026 after a debt-funded plant upgrade, while 68% of the IPO money sat unused at June 2025

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Technical report: trend, RSI, support and resistance, charts

Financial statements

Asiatic Laboratories Limited (ASIATICLAB) reported revenue of 2.90B BDT (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue2.90B1.77B1.39B1.29B1.47B1.45B
Cost of Revenue1.61B998.58M799.20M741.97M835.39M827.88M
Gross Profit1.30B766.89M586.03M547.28M637.39M623.38M
Selling, General & Admin311.21M238.82M244.62M211.05M221.76M207.87M
Operating Expenses311.21M238.82M244.62M211.05M221.76M207.87M
Operating Income987.81M528.06M341.41M336.23M415.63M415.51M
Interest Expense-303.08M-198.72M-49.98M-54.13M-41.02M-43.92M
Interest & Investment Income1.45M1.45M17.91M
Currency Exchange Gain (Loss)1.41M273.74K
Other Non Operating Income (Expenses)990.78K-95.11K-357.45K11.96M-260.75K-383.05K
Pretax Income687.17M330.70M308.99M294.07M375.76M371.48M
Income Tax Expense155.81M75.34M30.51M88.22M107.20M50.95M
Net Income531.35M255.36M278.48M205.85M268.56M320.52M
Net Income to Common531.35M255.36M278.48M205.85M268.56M320.52M
Shares Outstanding (Basic)122.39M122.39M98.89M93.86M87.85M87.85M
Shares Outstanding (Diluted)122.39M122.39M98.89M93.86M87.85M87.85M
EPS (Basic)4.342.092.822.193.063.65
EPS (Diluted)4.342.092.822.193.063.65
Free Cash Flow-290.23M-1.10B-474.97M13.01M51.60M56.91M
Free Cash Flow Per Share-2.37-8.97-4.800.140.590.65
Dividend Per Share1.001.001.00
Gross Margin44.72%43.44%42.31%42.45%43.28%42.95%
Operating Margin34.01%29.91%24.65%26.08%28.22%28.63%
Profit Margin18.29%14.46%20.10%15.97%18.23%22.09%
Free Cash Flow Margin-9.99%-62.16%-34.29%1.01%3.50%3.92%
EBITDA1.15B679.62M478.51M459.26M522.45M504.70M
EBITDA Margin39.60%38.50%34.54%35.62%35.47%34.78%
D&A For EBITDA162.41M151.56M137.10M123.02M106.82M89.19M
EBIT987.81M528.06M341.41M336.23M415.63M415.51M
EBIT Margin34.01%29.91%24.65%26.08%28.22%28.63%
Effective Tax Rate22.68%22.78%9.88%30.00%28.53%13.72%
Advertising Expenses5.14M7.45M7.41M7.36M6.11M

Balance sheet

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents22.15M17.73M159.42M446.74M7.89M8.98M
Cash & Short-Term Investments22.15M17.73M159.42M446.74M7.89M8.98M
Receivables809.67M649.64M401.76M372.02M278.02M192.20M
Inventory748.79M636.44M476.74M341.11M376.00M319.94M
Other Current Assets830.92M798.83M617.71M126.71M186.13M109.52M
Total Current Assets2.41B2.10B1.66B1.29B848.03M630.64M
Property, Plant & Equipment7.23B6.76B5.77B5.64B5.41B5.23B
Other Intangible Assets416.67K791.67K1.29M1.79M2.29M2.79M
Other Long-Term Assets1.00-1.001.00
Total Assets9.65B8.87B7.42B6.92B6.26B5.86B
Accounts Payable13.77M6.96M8.76M7.47M16.73M15.21M
Accrued Expenses88.08M49.13M59.12M38.34M39.65M34.91M
Short-Term Debt63.70M49.85M51.75M8.88M9.43M
Current Portion of Long-Term Debt167.81M260.73M17.19M58.54M78.43M83.15M
Current Portion of Leases15.66M15.76M11.15M12.19M21.44M16.72M
Current Income Taxes Payable252.34M105.31M101.80M112.35M145.45M71.71M
Other Current Liabilities27.61M13.22M-1.001.00
Total Current Liabilities565.28M514.82M247.86M280.64M310.57M231.11M
Long-Term Debt1.36B1.04B69.44M274.73M240.46M225.89M
Long-Term Leases37.10M31.17M37.44M47.13M32.76M32.62M
Long-Term Deferred Tax Liabilities653.53M659.38M631.79M657.46M433.03M401.04M
Other Long-Term Liabilities-1.001.00
Total Liabilities2.61B2.25B986.53M1.26B1.02B890.66M
Common Stock1.22B1.22B1.22B878.48M878.48M878.48M
Additional Paid-In Capital578.23M578.23M578.23M
Retained Earnings3.61B3.20B3.01B2.73B2.51B2.24B
Comprehensive Income & Other1.62B1.62B1.62B2.06B1.85B1.86B
Shareholders' Equity7.03B6.62B6.44B5.66B5.24B4.97B
Total Liabilities & Equity9.65B8.87B7.42B6.92B6.26B5.86B
Total Debt1.58B1.41B185.06M444.35M381.96M367.80M
Net Cash (Debt)-1.56B-1.39B-25.65M2.40M-374.08M-358.81M
Net Cash Per Share-12.71-11.39-0.260.03-4.26-4.08
Filing Date Shares Outstanding122.39M122.39M122.39M87.85M87.85M87.85M
Total Common Shares Outstanding122.39M122.39M122.39M87.85M87.85M87.85M
Working Capital1.85B1.59B1.41B1.01B537.46M399.53M
Book Value Per Share57.4654.0852.5864.4859.6856.61
Tangible Book Value7.03B6.62B6.43B5.66B5.24B4.97B
Tangible Book Value Per Share57.4654.0852.5764.4659.6656.58
Land3.16B3.14B
Buildings1.21B1.19B
Machinery2.25B1.38B
Construction In Progress297.67M42.09M78.14M41.32M46.57M

Cash flow statement

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income531.35M255.36M278.48M205.85M268.56M320.52M
Depreciation & Amortization164.98M164.98M150.74M136.91M121.31M104.90M
Other Amortization500.00K500.00K500.00K500.00K500.00K500.00K
Other Operating Activities472.00M258.39M44.35M76.94M77.36M44.20M
Change in Accounts Receivable-247.88M-247.88M-29.74M-94.00M-85.82M-15.91M
Change in Inventory-159.70M-159.70M-135.63M34.88M-56.06M-32.58M
Change in Accounts Payable-1.80M-1.80M1.29M-9.26M1.52M-4.86M
Change in Other Net Operating Assets-66.66M-66.66M1.71M20.69M4.82M15.23M
Operating Cash Flow692.80M203.20M311.71M372.50M332.20M432.01M
Capital Expenditures-983.03M-1.30B-786.68M-359.49M-280.60M-375.10M
Other Investing Activities1.00
Investing Cash Flow-983.03M-1.30B-786.68M-359.49M-280.60M-375.10M
Short-Term Debt Issued13.85M42.87M
Long-Term Debt Issued1.21B15.85M9.86M
Total Debt Issued727.72M1.23B58.73M9.86M
Short-Term Debt Repaid-1.90M-552.06K-309.15K
Long-Term Debt Repaid-14.98M-266.85M-15.14M-14.83M
Lease Payments-7.93M-14.98M-20.20M-15.14M-7.34M
Total Debt Repaid-71.63M-14.98M-268.74M-15.70M-15.14M
Net Debt Issued (Repaid)656.09M1.21B-268.74M58.73M-5.84M-15.14M
Common Dividends Paid-55.95M-59.34M
Other Financing Activities-303.18M-198.82M456.38M367.12M-48.29M-44.32M
Financing Cash Flow296.96M955.67M187.64M425.84M-54.13M-59.47M
Foreign Exchange Rate Adjustments1.43M271.82K
Miscellaneous Cash Flow Adjustments-1.001.00
Net Cash Flow6.73M-141.68M-287.33M438.86M-1.10M-2.28M
Free Cash Flow-290.23M-1.10B-474.97M13.01M51.60M56.91M
Free Cash Flow Margin-9.99%-62.16%-34.29%1.01%3.50%3.92%
Free Cash Flow Per Share-2.37-8.97-4.800.140.590.65
Levered Free Cash Flow-1.51B-1.10B-89.13M-63.14M-55.04M
Unlevered Free Cash Flow-1.39B-1.07B-55.30M-37.51M-27.59M
Free Cash Flow After Leases-298.16M-1.11B-495.17M13.01M36.45M49.57M
Cash Interest Paid303.18M198.82M49.98M54.13M41.02M43.92M
Cash Income Tax Paid28.33M15.76M43.31M65.74M69.73M44.10M
Change in Working Capital-476.04M-476.04M-162.36M-47.69M-135.53M-38.12M

Ratios

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization13.22B4.75B6.10B
Enterprise Value14.77B5.12B6.47B
Last Close Price108.0038.0847.32
PE Ratio24.8818.6021.89
PS Ratio4.552.694.40
PB Ratio1.880.720.95
P/TBV Ratio1.880.720.95
P/OCF Ratio19.0823.3719.55
EV/Sales Ratio5.092.904.67
EV/EBITDA Ratio12.707.5413.52
EV/EBIT Ratio14.969.7018.95
Debt / Equity Ratio0.220.210.030.080.070.07
Debt / EBITDA Ratio1.362.040.380.940.710.71
Debt / FCF Ratio34.157.406.46
Net Debt / Equity Ratio0.220.210.000.000.070.07
Net Debt / EBITDA Ratio1.352.050.05-0.010.720.71
Net Debt / FCF Ratio-5.36-1.27-0.05-0.187.256.30
Asset Turnover0.220.190.200.240.31
Inventory Turnover1.791.952.072.402.73
Quick Ratio1.471.302.262.920.920.87
Current Ratio4.274.086.684.582.732.73
Return on Equity (ROE)3.91%4.60%3.77%5.26%8.25%
Return on Assets (ROA)4.05%2.97%3.19%4.29%5.48%
Return on Invested Capital (ROIC)9.08%5.63%5.08%4.17%5.43%8.45%
Return on Capital Employed (ROCE)10.90%6.30%4.80%5.10%7.00%7.40%
Earnings Yield4.02%5.38%4.57%
FCF Yield-2.20%-23.11%-7.79%
Dividend Yield0.93%2.58%2.01%
Payout Ratio10.53%23.24%
Buyback Yield / Dilution-23.77%-23.77%-5.36%-6.84%
Total Shareholder Return-22.84%-21.19%-3.36%-6.84%